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RELIABILITY AND SENSITIVITY OF THE 20-METER WALK TEST
AMONG PATIENTS WITH KNEE OSTEOARTHRITIS
J.M. Motyl, J.B. Driban, E. McAdams, T.E. McAlindon. Tufts Med. Ctr.,
Boston, MA, USA
Purpose: The 20-meter walk test is a physical function measure
commonly used in clinical research studies and rehabilitation clinics to
measure gait speed and monitor changes in patients’ physical function
over time. Unfortunately, the reliability and sensitivity of this walk test
are not well deﬁned and therefore limit our ability to evaluate changes
in gait speed. The aim of this study was to assess the reliability and
sensitivity of the 20-meter walk test, at a self-selected pace, among
patients with knee osteoarthritis (OA).
Methods: This was a measurement reliability study that included
ﬁfteen consecutive participants enrolled in a randomized-controlled
trial of intra-articular corticosteroid injections for knee OA. The study
sample included consecutive participants attending screening (Day 1)
and baseline (Day 2) visits between July 2011 and December 2011. All
participants met the American College of Rheumatology criteria for OA;
had radiographic knee OA, as deﬁned by Kellgren-Lawrence grade 2 or
3; and knee synovitis, deﬁned by a synovial pouch depth greater than
2.0 mm measured by ultrasound. All participants were also required to
have knee pain symptoms, deﬁned as a WOMAC Osteoarthritis Index
(version 3.1, 5-point Likert) pain subscore > 2 at the beginning of their
ﬁrst visit (Day 1). All participants completed 4 trials on 2 separate days,
7 to 21 days apart (8 trials total). Each day was divided into 2 sessions,
which each involved 2 walking trials. Day 1 contained sessions 1 (trial 1
and 2) and session 2 (trial 3 and 4) and Day 2 contained session 3 (trial 5
and 6) and session 4 (trial 7 and 8). All trials were administered by the
same investigator following a standardized script and protocol. We
compared walk times between trials with Wilcoxon signed-rank tests.
We also calculated Spearman correlation coefﬁcients to assess the
relationship between sessions. Finally, smallest detectable differences
(SDD) were calculated to estimate the sensitivity of the 20-meter walk
test.
Results: Participants were 53% female, 67% (n ¼ 10) Caucasian, on
average 61.0  7.8 years of age and had a mean body mass index of 28.9
 5.4 kg/m2. Twelve participants (80%) had Kellegren-Lawrence Grade
¼ 3. WOMAC pain scores were 5.3 1.3 on Day 1 and 4.9 2.0 on Day 2.
The ﬁgure depicts walk times across trials. We found that walking times
in the ﬁrst session were slower than the second session (median
difference ¼ 0.53 seconds, -0.04 m/s; Table). We also found that the
correlation between session 1 and sessions 3 and 4 were lower than the
correlations between session 2 and sessions 3 and 4 (Table). Therefore,
we considered the ﬁrst session of each day a practice session and
calculated the SDD between the second session of each day (session 2
and 4). SDD were -2.59 seconds (walking slower) and 1.65 seconds
(walking faster). There was a potential systematic bias of participants
walking slower during the second session on Day 2 compared to the
second session of Day 1 (10 [67%] participants walked slower in session
4 compared to session 2; based on differences below zero).
Conclusions:We found that the average of the ﬁrst two 20-meter walk
times did not agree with subsequent average walk times among
participants with knee OA. Therefore, practice trials may be advised
prior to a measuring a participants walk time. Despite concerns about
thewalk times of session 1, the following sessions were reliable and had
good agreement. Finally, changes in walk time between -2.59 seconds
(walking slower) and 1.65 seconds (walking faster) should be consid-
ered within the range of normal variability of 20-meter walking speed.Table 1








Min, Max (sec) (95% CI)
Session 1 - Session2 0.53 < 0.01 -2.54, 4.81 0.88 (0.67, 0.96)
Session 1 - Session 3 0.31 0.22 -2.13, 3.09 0.78 (0.45, 0.92)
Session 1 - Session 4 0.12 0.28 -3.07, 4.39 0.78 (0.45, 0.92)
Session 2 - Session 3 -0.14 0.07 -3.49, 2.20 0.95 (0.85, 0.98)
Session 2 - Session 4 -0.04 0.19 -2.63, 1.69 0.94 (0.83, 0.98)
Note. P values are based on Wilcoxon signed-rank tests. 95% CI ¼ 95% conﬁdence
interval.251
MORTALITY IN OSTEOARTHRITIS: A SYSTEMATIC REVIEW
R. Liu, T.W. Huizinga, M. Kloppenburg. Leids Univ.ir Medisch Centrum,
Leiden, The Netherlands
Purpose: Study results concerning mortality in osteoarthritis (OA)
patients have been controversial. We conducted a systematic review to
determine the true association between OA and mortality.
Methods: A systematic search was performed in the databases MED-
LINE, EMBASE, COCHRANE, Web of Science, ScienceDirect, CINAHL and
Academic Search Premier up to October 2011. Two independent
reviewers identiﬁed studies that reported mortality for OA patients,
compared with a non-OA population. Study quality was also assessed
Information on study design, patient characteristics, OA status, duration
of follow-up, mortality assessment and outcomes were extracted for
each study.
Results: The electronic databases yielded 1598 individual articles of
which 1387 articles were excluded on the basis of title and 116 articles
on the basis of abstracts. Ninety-ﬁve articles were screened full-text and
only 27 articles met the inclusion criteria. Five articles were additionally
excluded due to multiple publications for the same population, the lack
of OA speciﬁc information or short follow-up time. Finally, 22 studies,
investigating 23 patient populations, were included in the present
review. Most studies involved knee or hip OA (n¼17). Comparisons
were mostly made with the general population using information from
the country's bureau of statistics. The quality of these studies varied
widely. Thirteen studies reported mortality in 14 study populations,
receiving either total knee or hip arthroplasty; the majority of these
studies found lower mortality rates for OA patients. Four studies,
generally of low quality, of which three hospital based found increased
mortality rates, whereas one study, in OA patients consulting their
general practitioners, did not. Five studies were based in the general
population; two high quality studies reported higher mortality rates,
while the other studies (of a varying quality) reported lower and equal
mortality rates for OA cases.
Conclusion: The heterogeneous quality of the studies has unfortunately
resulted in important limitations to our interpretation of the evidence.
The association between OA and mortality appears to be complex,
depending on the phenotype. Factors, such as selection bias, care
seeking behavior, OA subtype, etc could account for the observed
differences. Further studies are warranted.
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